119 related articles for article (PubMed ID: 24461987)
1. Necessity for rule out coronary artery disease with the positive findings of 18F-FDG-PET in case of systemic sarcoidosis.
Egashira T; Makino S; Kunitomi A; Okada M; Maekawa Y; Fukuda K
Int J Cardiol; 2014 Apr; 172(3):e401-2. PubMed ID: 24461987
[No Abstract] [Full Text] [Related]
2. F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis.
Simonen P; Lehtonen J; Kandolin R; Schildt J; Marjasuo S; Miettinen H; Airaksinen J; Vihinen T; Tuohinen S; Haataja P; Kupari M
Am J Cardiol; 2015 Nov; 116(10):1581-5. PubMed ID: 26411357
[TBL] [Abstract][Full Text] [Related]
3. [Contingent diagnosis of sarcoidosis by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) after completion of chemotherapy for malignant lymphoma].
Iino M; Iizuka C
Rinsho Ketsueki; 2012 May; 53(5):540-2. PubMed ID: 22728558
[TBL] [Abstract][Full Text] [Related]
4. Sarcoidosis manifesting as cardiac sarcoidosis and massive splenomegaly.
Kawano S; Kato J; Kawano N; Yoshimura Y; Masuyama H; Fukunaga T; Shimao Y; Mihara K; Ueda A; Toyoda K; Imamura T; Kitamura K
Intern Med; 2012; 51(1):65-9. PubMed ID: 22214625
[TBL] [Abstract][Full Text] [Related]
5. The role of 18F-FDG-PET and PET/CT in patients with sarcoidosis: an updated evidence-based review.
Treglia G; Annunziata S; Sobic-Saranovic D; Bertagna F; Caldarella C; Giovanella L
Acad Radiol; 2014 May; 21(5):675-84. PubMed ID: 24703482
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients.
Kaira K; Oriuchi N; Otani Y; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Endo K; Mori M
Chest; 2007 Apr; 131(4):1019-27. PubMed ID: 17426205
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of definite or suspected isolated cardiac sarcoidosis: application of cardiac magnetic resonance imaging and 18F-Fluoro-2-deoxyglucose positron-emission tomography/computerized tomography.
Tezuka D; Terashima M; Kato Y; Toriihara A; Hirasawa K; Sasaoka T; Yoshikawa S; Maejima Y; Ashikaga T; Suzuki J; Hirao K; Isobe M
J Card Fail; 2015 Apr; 21(4):313-22. PubMed ID: 25512195
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of unknown sarcoidosis associated to erythema nodosum with 18F-FDG PET/CT.
Rampin L; Musto A; Marzola MC; Tadayyon S; Ferretti A; Chondrogiannis S; Grassetto G; Rubello D
Rev Esp Med Nucl Imagen Mol; 2013; 32(3):190-2. PubMed ID: 23522858
[TBL] [Abstract][Full Text] [Related]
9. Use of whole-body FDG PET-CT to aid in the diagnosis of occult sarcoidosis.
Tannen BL; Ghesani NV; Frohman L; Eichler JD; Maldjian PD; Chu DS
Ocul Immunol Inflamm; 2008; 16(1):25-7. PubMed ID: 18379938
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG uptake as a surrogate marker for antecedent ischemia.
Dilsizian V
J Nucl Med; 2008 Dec; 49(12):1909-11. PubMed ID: 18997055
[No Abstract] [Full Text] [Related]
11. [Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report].
Kaneko M; Tomioka H; Kaneda T; Kubot M; Tani S; Fujii H; Katsuyama E; Okazaki M
Nihon Kokyuki Gakkai Zasshi; 2008 Jun; 46(6):505-9. PubMed ID: 18593000
[TBL] [Abstract][Full Text] [Related]
12. 18F-FDG PET successfully detects spinal cord sarcoidosis.
Ota K; Tsunemi T; Saito K; Yamanami F; Watanabe M; Irioka T; Mizusawa H
J Neurol; 2009 Nov; 256(11):1943-6. PubMed ID: 19685103
[TBL] [Abstract][Full Text] [Related]
13. Retrospective study of coronary uptake of 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: a preliminary study.
Williams G; Kolodny GM
Nucl Med Commun; 2009 Apr; 30(4):287-91. PubMed ID: 19238108
[TBL] [Abstract][Full Text] [Related]
14. [Sarcoidosis demonstrated by fluorodeoxyglucose positron emission tomography in a case of granulomatous myopathy].
Dufour JF; Billotey C; Streichenberger N; Bouhour F; Broussolle C; Sève P
Rev Med Interne; 2007 Aug; 28(8):568-70. PubMed ID: 17445952
[TBL] [Abstract][Full Text] [Related]
15. Whole-body 18FDG PET-CT imaging of systemic sarcoidosis: ophthalmic oncology and uveitis.
Shulman JP; Latkany P; Chin KJ; Finger PT
Ocul Immunol Inflamm; 2009; 17(2):95-100. PubMed ID: 19412870
[TBL] [Abstract][Full Text] [Related]
16. FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports.
Takanami K; Kaneta T; Yamada T; Kinomura S; Yamada S; Fukuda H; Takahashi S
Clin Nucl Med; 2008 Apr; 33(4):258-61. PubMed ID: 18356663
[TBL] [Abstract][Full Text] [Related]
17. Advanced imaging of cardiac sarcoidosis.
Schatka I; Bengel FM
J Nucl Med; 2014 Jan; 55(1):99-106. PubMed ID: 24232870
[TBL] [Abstract][Full Text] [Related]
18. Sarcoidosis mimicking metastatic breast cancer on FDG PET/CT.
Zivin S; David O; Lu Y
Intern Med; 2014; 53(21):2555-6. PubMed ID: 25366024
[No Abstract] [Full Text] [Related]
19. [Use of positron emission tomography in sarcoidosis].
Bonardel G; Carmoi T; Gontier E; Lecoules S; Cambon A; Foehrenbach H; Algayres JP
Rev Med Interne; 2011 Feb; 32(2):101-8. PubMed ID: 20846762
[TBL] [Abstract][Full Text] [Related]
20. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis.
Ishimaru S; Tsujino I; Takei T; Tsukamoto E; Sakaue S; Kamigaki M; Ito N; Ohira H; Ikeda D; Tamaki N; Nishimura M
Eur Heart J; 2005 Aug; 26(15):1538-43. PubMed ID: 15809286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
